Welcome to our dedicated page for Evolv Technologies Hldngs SEC filings (Ticker: EVLV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The EVLV SEC filings page on Stock Titan aggregates regulatory documents for Evolv Technologies Holdings, Inc., whose Class A common stock and warrants trade on The Nasdaq Stock Market under the symbols EVLV and EVLVW. These filings provide structured insight into how the company reports its financial performance, capital structure, governance decisions, and key agreements related to its AI-powered security screening business.
Among the most closely watched documents for Evolv are its annual reports on Form 10-K and quarterly reports on Form 10-Q, which detail revenue composition between recurring subscription and non-recurring product and services, discuss metrics such as Annual Recurring Revenue, and describe risks and operational considerations connected to its security technology offerings. Current reports on Form 8-K disclose specific material events, including the announcement of quarterly financial results, entry into credit agreements, changes in executive roles, and outcomes of shareholder votes at the annual meeting.
Filings also describe Evolv’s capital and financing arrangements, such as senior secured credit facilities documented in a Credit, Security and Guaranty Agreement, and registration statements or post-effective amendments that address the registration of securities and warrant exercises. Proxy materials and related disclosures explain matters submitted to stockholders, including director elections, advisory votes on executive compensation, and auditor ratification.
On Stock Titan, EVLV filings are updated as new documents are posted to the SEC’s EDGAR system. AI-powered summaries help explain lengthy filings by highlighting key points, such as changes in liquidity, covenant requirements, revenue mix, or governance decisions, without replacing the underlying source documents. Users can also review Section 16 and Form 4 filings to monitor insider transactions and equity awards, adding another dimension to their analysis of Evolv’s governance and incentive structures.
Together, these filings form a detailed record of how Evolv communicates with regulators and investors about its financial condition, risk factors, and significant corporate events related to its AI-based security technology business.
Evolv Technologies Holdings, Inc. (EVLV) reported an insider share purchase by its President & CEO and Director, John Kedzierski. On 11/21/2025, the reporting person bought 8,000 shares of Class A common stock in an open market transaction at a weighted average price of $5.91 per share. The filing notes the shares were acquired in multiple trades at prices ranging from $5.89 to $5.91, and the reporting person has offered to provide full trade details upon request. After this transaction, the insider directly holds 8,000 shares.
Evolv Technologies Holdings, Inc. (EVLV) reported an insider share purchase by a director. On 11/21/2025, the reporting person acquired 15,000 shares of Class A common stock in an open market purchase at a price of $5.6797 per share, through an IRA account. Following this transaction, the director beneficially owns 44,081 shares indirectly through the IRA and 331,960 shares directly. The filing is made by a single reporting person in the capacity of director, highlighting continued personal equity ownership in the company.
Evolv Technologies Holdings, Inc. (EVLV) director Richard Shapiro reported multiple open-market purchases of Class A common stock on 11/20/2025. He bought 30,000 shares directly at a weighted average price of about $6.00, with individual trades ranging from $5.97 to $6.02. He also acquired 7,500 shares held by a trust over which he has voting and dispositive power and 8,800 shares held by his spouse in a retirement plan, both at weighted average prices around $6.02. After these transactions, he directly owned 52,515 shares, while indirect holdings included shares in the trust and accounts related to his spouse.
Evolv Technologies Holdings, Inc. (EVLV) director reported an option exercise and share sale. On 11/17/2025, the reporting person exercised stock options to acquire 80,745 shares of Class A common stock at $0.24 per share and then sold 80,745 shares at a weighted average price of $5.8, with individual trades ranging from $5.69 to $5.99. These transactions were made under a Rule 10b5-1 trading plan entered into on June 12, 2025. After the transactions, the reporting person directly beneficially owned 2,083,961 shares, with an additional 151,135 shares held indirectly through the Family Horizon Trust, and continued to hold 1,462,229 stock options.
Evolv Technologies (EVLV) reported Q3 results showing faster growth and improved losses. Total revenue was $42.9 million, up from $27.4 million a year ago, led by subscription revenue of $22.7 million, service revenue of $7.8 million, product revenue of $9.2 million, and license/other revenue of $3.1 million. Gross profit rose to $21.3 million. The company posted a net loss of $1.8 million versus a $30.4 million loss last year, reflecting lower operating expenses and favorable fair value adjustments.
Liquidity improved with positive operating cash flow of $3.1 million for the nine months. Cash, cash equivalents, and marketable securities were $56.2 million as of September 30, 2025. Evolv entered a new $75.0 million senior secured credit facility, drawing $30.0 million, leaving $45.0 million available. Deferred revenue increased to $96.4 million, and annual recurring revenue was $117.2 million as of September 30, 2025. Shares outstanding were 174,617,589 as of November 7, 2025.
Evolv Technologies Holdings, Inc. reported that it announced financial results for the fiscal quarter ended September 30, 2025. The company furnished the full press release as Exhibit 99.1 to this Form 8-K.
The information under Item 2.02, including Exhibit 99.1, is furnished and not deemed filed under Section 18 of the Exchange Act, and is not incorporated by reference except as expressly stated.
Evolv Technologies Holdings (EVLV): Founder & Chief Growth Officer Anil Chitkara reported option exercises and open‑market sales. On 10/24/2025 and 10/27/2025, he exercised a total of 360,000 stock options at $0.24 and $0.42 per share and sold 360,000 Class A shares at a weighted average price of $8.20. The 10/24 sales occurred within $8.03–$8.34, and the 10/27 sale within $8.13–$8.30.
Following these transactions, he beneficially owned 1,275,100 shares directly. Option footnotes state one grant vested 25% on January 31, 2018 with 36 monthly installments thereafter, and another vested 25% on January 1, 2022 with 36 monthly installments thereafter.
Evolv Technologies Holdings (EVLV) reported a director’s Form 4 for transactions on 10/15/2025. The insider exercised 80,745 stock options at $0.24 and then sold 80,745 Class A shares at a $8.26 weighted average, with sales executed between $8.03 and $8.54, pursuant to a Rule 10b5-1 plan entered on June 12, 2025.
Following the transactions, the insider beneficially owned 2,083,961 shares directly and 151,135 shares indirectly (held by Family Horizon Trust), and held 1,542,974 derivative securities (stock options).
Gates Frontier, LLC and William H. Gates III reported beneficial ownership of 2,365,664 shares of Evolv Technologies Holdings, Inc. Class A common stock, representing 1.4% of the outstanding shares. The percent is calculated using 171,891,467 shares outstanding as of August 11, 2025, per the issuer's report. Gates Frontier is organized in Washington and WHG is a U.S. citizen. The filing states the shares were not acquired to influence control of the issuer and includes execution by an authorized attorney-in-fact dated September 22, 2025.
Michael Ellenbogen, Founder and Chief Innovation Officer of Evolv Technologies Holdings, Inc. (EVLV), reported transactions on 09/15/2025. He exercised 80,745 stock options with a $0.24 exercise price, resulting in acquisition of 80,745 Class A shares. On the same date he sold 80,745 Class A shares under a Rule 10b5-1 plan at a weighted average price of $8.46 per share (individual sale prices ranged $8.34–$8.80). Following the transactions, he reported 2,083,961 Class A shares held directly and 151,135 held indirectly by the Family Horizon Trust. The option expires 09/13/2027 and vested 25% on 01/31/2018 with subsequent monthly vesting; the Form 4 was signed by an attorney-in-fact on 09/17/2025.